Annual Income Statements for Bain Capital Specialty Finance
This table shows Bain Capital Specialty Finance's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.
Quarterly Income Statements for Bain Capital Specialty Finance
This table shows Bain Capital Specialty Finance's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.
| Metric |
|
Q4 2023 |
Q1 2024 |
Q2 2024 |
Q3 2024 |
Q4 2024 |
Q1 2025 |
Q2 2025 |
Q3 2025 |
Q4 2025 |
Q1 2026 |
Q2 2026 |
| Net Income / (Loss) Attributable to Common Shareholders |
|
-9.91 |
35 |
29 |
33 |
22 |
-34 |
16 |
19 |
-21 |
-13 |
14 |
| Consolidated Net Income / (Loss) |
|
-18 |
39 |
28 |
31 |
34 |
-34 |
16 |
22 |
-20 |
-13 |
14 |
| Net Income / (Loss) Continuing Operations |
|
-18 |
39 |
28 |
31 |
34 |
-34 |
16 |
22 |
-20 |
-13 |
14 |
| Total Pre-Tax Income |
|
-18 |
39 |
28 |
31 |
34 |
-34 |
16 |
22 |
-20 |
-13 |
14 |
| Total Revenue |
|
-28 |
62 |
49 |
52 |
53 |
-31 |
18 |
40 |
-48 |
-9.74 |
27 |
| Net Interest Income / (Expense) |
|
-77 |
38 |
37 |
37 |
35 |
-19 |
-22 |
34 |
-128 |
-20 |
25 |
| Total Interest Income |
|
-58 |
56 |
55 |
55 |
56 |
0.00 |
0.00 |
54 |
-108 |
0.00 |
45 |
| Investment Securities Interest Income |
|
- |
56 |
55 |
55 |
56 |
- |
- |
54 |
- |
- |
45 |
| Total Interest Expense |
|
19 |
18 |
18 |
18 |
21 |
19 |
22 |
20 |
20 |
20 |
21 |
| Long-Term Debt Interest Expense |
|
19 |
18 |
18 |
18 |
21 |
19 |
22 |
20 |
20 |
20 |
21 |
| Total Non-Interest Income |
|
49 |
24 |
12 |
14 |
18 |
-12 |
40 |
5.88 |
80 |
11 |
2.43 |
| Other Service Charges |
|
2.38 |
5.26 |
3.14 |
5.70 |
4.50 |
2.88 |
4.16 |
1.61 |
1.24 |
1.50 |
1.81 |
| Net Realized & Unrealized Capital Gains on Investments |
|
62 |
5.17 |
-5.45 |
-2.89 |
0.47 |
-15 |
36 |
-7.39 |
103 |
9.01 |
-15 |
| Other Non-Interest Income |
|
- |
14 |
14 |
11 |
13 |
- |
- |
12 |
- |
- |
15 |
| Total Non-Interest Expense |
|
-11 |
22 |
22 |
20 |
19 |
3.29 |
2.64 |
18 |
-28 |
2.77 |
13 |
| Insurance Policy Acquisition Costs |
|
- |
9.23 |
7.92 |
7.02 |
4.70 |
- |
- |
4.60 |
- |
- |
0.80 |
| Other Operating Expenses |
|
-6.67 |
13 |
14 |
13 |
14 |
3.29 |
2.64 |
13 |
-18 |
2.77 |
12 |
| Basic Earnings per Share |
|
$0.49 |
$0.55 |
$0.45 |
$0.51 |
$0.34 |
$0.44 |
$0.37 |
$0.29 |
$0.43 |
$0.05 |
$0.22 |
| Weighted Average Basic Shares Outstanding |
|
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.68M |
64.87M |
64.87M |
64.82M |
64.87M |
64.87M |
| Diluted Earnings per Share |
|
$0.49 |
$0.55 |
$0.45 |
$0.51 |
$0.34 |
$0.44 |
$0.37 |
$0.29 |
$0.43 |
$0.05 |
$0.22 |
| Weighted Average Diluted Shares Outstanding |
|
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.68M |
64.87M |
64.87M |
64.82M |
64.87M |
64.87M |
| Basic & Diluted Earnings per Share |
|
- |
- |
$0.51 |
$0.53 |
- |
- |
- |
$0.45 |
- |
- |
$0.44 |
| Weighted Average Basic & Diluted Shares Outstanding |
|
64.56M |
64.56M |
64.56M |
64.56M |
64.61M |
64.87M |
64.87M |
64.87M |
64.87M |
64.87M |
64.87M |
Annual Cash Flow Statements for Bain Capital Specialty Finance
This table details how cash moves in and out of Bain Capital Specialty Finance's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.
| Metric |
|
2020 |
2021 |
2022 |
2023 |
2024 |
2025 |
| Net Change in Cash & Equivalents |
|
13 |
127 |
-79 |
-12 |
-13 |
-42 |
| Net Cash From Operating Activities |
|
89 |
266 |
-317 |
219 |
-27 |
30 |
| Net Cash From Continuing Operating Activities |
|
89 |
266 |
-317 |
219 |
-27 |
30 |
| Net Income / (Loss) Continuing Operations |
|
8.28 |
120 |
105 |
123 |
119 |
99 |
| Consolidated Net Income / (Loss) |
|
8.28 |
120 |
105 |
123 |
119 |
99 |
| Amortization Expense |
|
-3.23 |
0.06 |
-1.04 |
-1.76 |
-1.13 |
0.05 |
| Non-Cash Adjustments to Reconcile Net Income |
|
78 |
167 |
-393 |
109 |
-125 |
-45 |
| Changes in Operating Assets and Liabilities, net |
|
-22 |
-21 |
-28 |
-12 |
-21 |
-24 |
| Net Cash From Investing Activities |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Net Cash From Continuing Investing Activities |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Net Cash From Financing Activities |
|
-77 |
-139 |
238 |
-231 |
14 |
-72 |
| Net Cash From Continuing Financing Activities |
|
-77 |
-139 |
238 |
-231 |
14 |
-72 |
| Issuance of Debt |
|
597 |
1,425 |
793 |
348 |
867 |
1,306 |
| Issuance of Common Equity |
|
132 |
- |
- |
0.00 |
0.00 |
5.48 |
| Repayment of Debt |
|
-716 |
-1,476 |
-467 |
-480 |
-738 |
-1,238 |
| Payment of Dividends |
|
-86 |
-88 |
-88 |
-99 |
-114 |
-146 |
| Cash Interest Paid |
|
68 |
47 |
43 |
75 |
70 |
77 |
| Cash Income Taxes Paid |
|
0.00 |
0.24 |
0.13 |
0.83 |
2.25 |
3.34 |
Quarterly Cash Flow Statements for Bain Capital Specialty Finance
This table details how cash moves in and out of Bain Capital Specialty Finance's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.
| Metric |
|
Q4 2023 |
Q1 2024 |
Q2 2024 |
Q3 2024 |
Q4 2024 |
Q1 2025 |
Q2 2025 |
Q3 2025 |
Q4 2025 |
Q1 2026 |
Q2 2026 |
| Net Change in Cash & Equivalents |
|
6.57 |
10 |
-24 |
-39 |
40 |
-5.29 |
78 |
-88 |
-28 |
-25 |
98 |
| Net Cash From Operating Activities |
|
149 |
-64 |
192 |
-136 |
-20 |
-7.27 |
0.65 |
9.00 |
27 |
27 |
71 |
| Net Cash From Continuing Operating Activities |
|
148 |
-64 |
193 |
-136 |
-20 |
-7.27 |
0.65 |
9.00 |
27 |
27 |
71 |
| Net Income / (Loss) Continuing Operations |
|
31 |
35 |
29 |
33 |
22 |
29 |
24 |
19 |
28 |
3.39 |
14 |
| Consolidated Net Income / (Loss) |
|
31 |
35 |
29 |
33 |
22 |
29 |
24 |
19 |
28 |
3.39 |
14 |
| Amortization Expense |
|
-0.01 |
-0.58 |
-0.09 |
-0.03 |
-0.43 |
-0.41 |
0.05 |
0.41 |
-0.01 |
-0.21 |
1.38 |
| Non-Cash Adjustments to Reconcile Net Income |
|
119 |
-102 |
174 |
-161 |
-34 |
-49 |
-6.65 |
-26 |
37 |
32 |
77 |
| Changes in Operating Assets and Liabilities, net |
|
-2.76 |
3.49 |
-11 |
-7.48 |
-7.87 |
14 |
-16 |
16 |
-38 |
-9.02 |
-22 |
| Net Cash From Financing Activities |
|
-142 |
74 |
-217 |
97 |
60 |
1.98 |
78 |
-97 |
-55 |
-51 |
27 |
| Net Cash From Continuing Financing Activities |
|
-142 |
74 |
-217 |
97 |
60 |
1.98 |
78 |
-97 |
-55 |
-51 |
27 |
| Issuance of Debt |
|
20 |
198 |
99 |
268 |
302 |
459 |
300 |
406 |
141 |
643 |
84 |
| Repayment of Debt |
|
-135 |
-97 |
-286 |
-142 |
-213 |
-404 |
-193 |
-473 |
-167 |
-657 |
-30 |
| Payment of Dividends |
|
-27 |
-27 |
-29 |
-29 |
-29 |
-58 |
-29 |
-29 |
-29 |
-37 |
-27 |
| Cash Interest Paid |
|
20 |
18 |
18 |
16 |
19 |
20 |
18 |
20 |
19 |
20 |
22 |
| Cash Income Taxes Paid |
|
0.00 |
2.25 |
- |
0.16 |
-0.16 |
3.34 |
- |
- |
- |
0.00 |
3.36 |
Annual Balance Sheets for Bain Capital Specialty Finance
This table presents Bain Capital Specialty Finance's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.
| Metric |
|
2021 |
2022 |
2023 |
2024 |
2025 |
| Total Assets |
|
2,571 |
2,592 |
2,472 |
2,632 |
2,663 |
| Cash and Due from Banks |
|
117 |
30 |
43 |
52 |
23 |
| Restricted Cash |
|
86 |
66 |
63 |
46 |
33 |
| Trading Account Securities |
|
5.32 |
0.06 |
0.00 |
2,436 |
0.00 |
| Loans and Leases, Net of Allowance |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Deferred Acquisition Cost |
|
2.18 |
3.74 |
2.80 |
- |
3.54 |
| Other Assets |
|
77 |
100 |
2,351 |
83 |
100 |
| Total Liabilities & Shareholders' Equity |
|
2,571 |
2,592 |
2,472 |
2,632 |
2,663 |
| Total Liabilities |
|
1,471 |
1,476 |
1,336 |
1,492 |
1,545 |
| Accrued Interest Payable |
|
7.06 |
12 |
13 |
14 |
12 |
| Long-Term Debt |
|
1,415 |
1,385 |
1,256 |
1,390 |
1,471 |
| Other Long-Term Liabilities |
|
49 |
79 |
48 |
60 |
62 |
| Commitments & Contingencies |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Total Equity & Noncontrolling Interests |
|
1,100 |
1,116 |
1,136 |
1,140 |
1,117 |
| Total Preferred & Common Equity |
|
1,100 |
1,116 |
1,136 |
1,140 |
1,117 |
| Total Common Equity |
|
1,168 |
1,116 |
1,136 |
1,140 |
1,117 |
| Common Stock |
|
1,168 |
1,168 |
1,168 |
1,160 |
1,161 |
| Retained Earnings |
|
- |
-52 |
-32 |
-20 |
-44 |
Quarterly Balance Sheets for Bain Capital Specialty Finance
This table presents Bain Capital Specialty Finance's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.
| Metric |
|
Q1 2023 |
Q2 2023 |
Q3 2023 |
Q1 2024 |
Q2 2024 |
Q3 2024 |
Q1 2025 |
Q2 2025 |
Q3 2025 |
Q1 2026 |
Q2 2026 |
| Total Assets |
|
2,606 |
2,675 |
2,566 |
2,580 |
2,415 |
2,544 |
2,642 |
2,774 |
2,716 |
2,602 |
2,620 |
| Cash and Due from Banks |
|
23 |
88 |
65 |
47 |
18 |
25 |
10 |
28 |
41 |
13 |
97 |
| Restricted Cash |
|
51 |
36 |
26 |
74 |
67 |
29 |
56 |
137 |
26 |
18 |
18 |
| Trading Account Securities |
|
1.11 |
0.06 |
5.85 |
0.92 |
0.65 |
- |
1.47 |
0.00 |
0.00 |
2,476 |
2,370 |
| Loans and Leases, Net of Allowance |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Other Assets |
|
125 |
161 |
2,443 |
2,449 |
91 |
77 |
2,509 |
105 |
2,590 |
78 |
109 |
| Total Liabilities & Shareholders' Equity |
|
2,606 |
2,675 |
2,566 |
2,580 |
2,415 |
2,544 |
2,642 |
2,774 |
2,716 |
2,602 |
2,620 |
| Total Liabilities |
|
1,485 |
1,550 |
1,434 |
1,438 |
1,272 |
1,397 |
1,498 |
1,635 |
1,587 |
1,508 |
1,540 |
| Accrued Interest Payable |
|
14 |
16 |
15 |
13 |
12 |
13 |
12 |
14 |
13 |
11 |
8.60 |
| Other Short-Term Payables |
|
- |
- |
- |
- |
- |
- |
0.00 |
- |
- |
17 |
13 |
| Long-Term Debt |
|
1,408 |
1,490 |
1,370 |
1,358 |
1,174 |
1,301 |
1,451 |
1,563 |
1,496 |
1,455 |
1,501 |
| Other Long-Term Liabilities |
|
63 |
44 |
42 |
49 |
87 |
83 |
25 |
59 |
63 |
6.27 |
2.39 |
| Commitments & Contingencies |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Total Equity & Noncontrolling Interests |
|
1,168 |
1,126 |
1,133 |
1,143 |
1,143 |
1,147 |
1,145 |
1,139 |
1,129 |
1,094 |
1,080 |
| Total Preferred & Common Equity |
|
1,121 |
1,126 |
1,133 |
1,143 |
1,143 |
1,147 |
1,145 |
1,139 |
1,129 |
1,094 |
1,080 |
| Total Common Equity |
|
1,168 |
1,126 |
1,133 |
1,143 |
1,143 |
1,147 |
1,145 |
1,139 |
1,129 |
1,094 |
1,080 |
| Common Stock |
|
1,168 |
1,168 |
1,168 |
1,165 |
1,165 |
1,165 |
1,164 |
1,164 |
1,164 |
1,161 |
1,161 |
| Retained Earnings |
|
- |
-43 |
-36 |
-23 |
-23 |
-19 |
-20 |
-25 |
-36 |
-68 |
-81 |
Annual Metrics And Ratios for Bain Capital Specialty Finance
This table displays calculated financial ratios and metrics derived from Bain Capital Specialty Finance's official financial filings.
| Metric |
|
2020 |
2021 |
2022 |
2023 |
2024 |
2025 |
| DEI Shares Outstanding |
|
- |
- |
- |
- |
- |
64,868,507.00 |
| DEI Adjusted Shares Outstanding |
|
- |
- |
- |
- |
- |
64,868,507.00 |
| DEI Earnings Per Adjusted Shares Outstanding |
|
- |
- |
- |
- |
- |
-0.20 |
| Growth Metrics |
|
- |
- |
- |
- |
- |
- |
| Revenue Growth |
|
0.00% |
481.63% |
13.00% |
-106.66% |
1,854.77% |
-100.84% |
| EBITDA Growth |
|
0.00% |
563.96% |
13.26% |
-121.30% |
617.59% |
-109.97% |
| EBIT Growth |
|
0.00% |
321.00% |
14.31% |
-119.64% |
661.08% |
-109.92% |
| NOPAT Growth |
|
0.00% |
415.72% |
14.31% |
-113.75% |
901.54% |
-106.94% |
| Net Income Growth |
|
0.00% |
321.00% |
14.31% |
-119.64% |
661.08% |
-109.92% |
| EPS Growth |
|
0.00% |
1,228.57% |
-12.37% |
17.18% |
-3.14% |
-17.30% |
| Operating Cash Flow Growth |
|
0.00% |
196.98% |
-219.31% |
169.21% |
-112.36% |
208.95% |
| Free Cash Flow Firm Growth |
|
0.00% |
0.00% |
105.52% |
-30.24% |
-105.97% |
-1,117.57% |
| Invested Capital Growth |
|
0.00% |
0.00% |
-0.53% |
-4.37% |
5.75% |
2.30% |
| Revenue Q/Q Growth |
|
0.00% |
0.00% |
0.00% |
-110.47% |
60.59% |
-101.83% |
| EBITDA Q/Q Growth |
|
0.00% |
0.00% |
0.00% |
-142.75% |
64.46% |
-132.40% |
| EBIT Q/Q Growth |
|
0.00% |
0.00% |
0.00% |
-138.44% |
64.43% |
-132.22% |
| NOPAT Q/Q Growth |
|
0.00% |
0.00% |
0.00% |
-127.93% |
64.43% |
-122.56% |
| Net Income Q/Q Growth |
|
0.00% |
0.00% |
0.00% |
-134.37% |
64.43% |
-132.22% |
| EPS Q/Q Growth |
|
0.00% |
0.00% |
0.00% |
0.00% |
-7.50% |
6.25% |
| Operating Cash Flow Q/Q Growth |
|
0.00% |
0.00% |
-1.95% |
64.08% |
-119.14% |
267.65% |
| Free Cash Flow Firm Q/Q Growth |
|
0.00% |
0.00% |
0.00% |
0.00% |
-104.08% |
50.81% |
| Invested Capital Q/Q Growth |
|
0.00% |
0.00% |
0.00% |
-4.41% |
3.38% |
-1.40% |
| Profitability Metrics |
|
- |
- |
- |
- |
- |
- |
| EBITDA Margin |
|
0.00% |
64.28% |
64.42% |
0.00% |
60.79% |
0.00% |
| EBIT Margin |
|
0.00% |
64.24% |
64.99% |
0.00% |
61.31% |
0.00% |
| Profit (Net Income) Margin |
|
0.00% |
64.24% |
64.99% |
0.00% |
61.31% |
0.00% |
| Tax Burden Percent |
|
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
| Interest Burden Percent |
|
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
| Effective Tax Rate |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| Return on Invested Capital (ROIC) |
|
0.00% |
8.33% |
4.77% |
0.00% |
5.36% |
0.00% |
| ROIC Less NNEP Spread (ROIC-NNEP) |
|
0.00% |
8.33% |
4.77% |
0.00% |
5.36% |
0.00% |
| Return on Net Nonoperating Assets (RNNOA) |
|
0.00% |
10.72% |
6.03% |
0.00% |
6.24% |
0.00% |
| Return on Equity (ROE) |
|
0.00% |
19.05% |
10.81% |
-2.09% |
11.60% |
-1.16% |
| Cash Return on Invested Capital (CROIC) |
|
0.00% |
-191.67% |
5.30% |
3.79% |
-0.23% |
-2.63% |
| Operating Return on Assets (OROA) |
|
0.00% |
4.07% |
4.64% |
0.00% |
5.17% |
0.00% |
| Return on Assets (ROA) |
|
0.00% |
4.07% |
4.64% |
0.00% |
5.17% |
0.00% |
| Return on Common Equity (ROCE) |
|
0.00% |
20.23% |
11.14% |
-2.09% |
11.60% |
-1.16% |
| Return on Equity Simple (ROE_SIMPLE) |
|
0.00% |
9.52% |
10.73% |
-2.07% |
11.58% |
-1.17% |
| Net Operating Profit after Tax (NOPAT) |
|
-33 |
105 |
120 |
-16 |
132 |
-9.17 |
| NOPAT Margin |
|
0.00% |
64.24% |
64.99% |
0.00% |
61.31% |
0.00% |
| Net Nonoperating Expense Percent (NNEP) |
|
0.00% |
0.00% |
0.00% |
0.53% |
0.00% |
0.27% |
| SG&A Expenses to Revenue |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| Operating Expenses to Revenue |
|
0.00% |
35.76% |
35.01% |
0.00% |
38.69% |
0.00% |
| Earnings before Interest and Taxes (EBIT) |
|
-47 |
105 |
120 |
-24 |
132 |
-13 |
| Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA) |
|
-23 |
105 |
119 |
-25 |
131 |
-13 |
| Valuation Ratios |
|
- |
- |
- |
- |
- |
- |
| Price to Book Value (P/BV) |
|
0.00 |
0.00 |
0.54 |
0.75 |
0.97 |
0.81 |
| Price to Tangible Book Value (P/TBV) |
|
0.00 |
0.00 |
0.54 |
0.75 |
0.97 |
0.81 |
| Price to Revenue (P/Rev) |
|
0.00 |
0.00 |
3.25 |
0.00 |
5.11 |
0.00 |
| Price to Earnings (P/E) |
|
0.00 |
0.00 |
5.68 |
0.00 |
9.22 |
0.00 |
| Dividend Yield |
|
18.31% |
12.71% |
14.88% |
12.15% |
8.09% |
14.02% |
| Earnings Yield |
|
0.00% |
0.00% |
17.62% |
0.00% |
10.85% |
0.00% |
| Enterprise Value to Invested Capital (EV/IC) |
|
0.00 |
0.00 |
0.75 |
0.84 |
0.95 |
0.90 |
| Enterprise Value to Revenue (EV/Rev) |
|
0.00 |
0.00 |
10.24 |
0.00 |
11.12 |
0.00 |
| Enterprise Value to EBITDA (EV/EBITDA) |
|
0.00 |
0.00 |
15.90 |
0.00 |
18.29 |
0.00 |
| Enterprise Value to EBIT (EV/EBIT) |
|
0.00 |
0.00 |
15.76 |
0.00 |
18.13 |
0.00 |
| Enterprise Value to NOPAT (EV/NOPAT) |
|
0.00 |
0.00 |
15.76 |
0.00 |
18.13 |
0.00 |
| Enterprise Value to Operating Cash Flow (EV/OCF) |
|
0.00 |
0.00 |
0.00 |
9.12 |
0.00 |
78.49 |
| Enterprise Value to Free Cash Flow (EV/FCFF) |
|
0.00 |
0.00 |
14.19 |
21.54 |
0.00 |
0.00 |
| Leverage & Solvency |
|
- |
- |
- |
- |
- |
- |
| Debt to Equity |
|
0.00 |
1.29 |
1.24 |
1.11 |
1.22 |
1.32 |
| Long-Term Debt to Equity |
|
0.00 |
1.29 |
1.24 |
1.11 |
1.22 |
1.32 |
| Financial Leverage |
|
0.00 |
1.29 |
1.26 |
1.17 |
1.16 |
1.27 |
| Leverage Ratio |
|
0.00 |
2.34 |
2.33 |
2.25 |
2.24 |
2.35 |
| Compound Leverage Factor |
|
0.00 |
2.34 |
2.33 |
2.25 |
2.24 |
2.35 |
| Debt to Total Capital |
|
0.00% |
56.26% |
55.37% |
52.50% |
54.95% |
56.83% |
| Short-Term Debt to Total Capital |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| Long-Term Debt to Total Capital |
|
0.00% |
56.26% |
55.37% |
52.50% |
54.95% |
56.83% |
| Preferred Equity to Total Capital |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| Noncontrolling Interests to Total Capital |
|
0.00% |
-2.72% |
0.00% |
0.00% |
0.00% |
0.00% |
| Common Equity to Total Capital |
|
0.00% |
46.46% |
44.63% |
47.50% |
45.05% |
43.17% |
| Debt to EBITDA |
|
0.00 |
13.50 |
11.67 |
-49.67 |
10.62 |
-112.76 |
| Net Debt to EBITDA |
|
0.00 |
11.56 |
10.86 |
-45.47 |
9.88 |
-108.48 |
| Long-Term Debt to EBITDA |
|
0.00 |
13.50 |
11.67 |
-49.67 |
10.62 |
-112.76 |
| Debt to NOPAT |
|
0.00 |
13.51 |
11.57 |
-76.26 |
10.53 |
-160.48 |
| Net Debt to NOPAT |
|
0.00 |
11.56 |
10.76 |
-69.82 |
9.80 |
-154.39 |
| Long-Term Debt to NOPAT |
|
0.00 |
13.51 |
11.57 |
-76.26 |
10.53 |
-160.48 |
| Noncontrolling Interest Sharing Ratio |
|
0.00% |
-6.22% |
-3.09% |
0.00% |
0.00% |
0.00% |
| Liquidity Ratios |
|
- |
- |
- |
- |
- |
- |
| Cash Flow Metrics |
|
- |
- |
- |
- |
- |
- |
| Free Cash Flow to Firm (FCFF) |
|
0.00 |
-2,410 |
133 |
93 |
-5.54 |
-67 |
| Operating Cash Flow to CapEx |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| Free Cash Flow to Firm to Interest Expense |
|
0.00 |
-46.94 |
2.54 |
1.16 |
-0.07 |
-0.84 |
| Operating Cash Flow to Interest Expense |
|
1.41 |
5.17 |
-6.06 |
2.74 |
-0.36 |
0.37 |
| Operating Cash Flow Less CapEx to Interest Expense |
|
1.41 |
5.17 |
-6.06 |
2.74 |
-0.36 |
0.37 |
| Efficiency Ratios |
|
- |
- |
- |
- |
- |
- |
| Asset Turnover |
|
0.00 |
0.06 |
0.07 |
0.00 |
0.08 |
0.00 |
| Fixed Asset Turnover |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Capital & Investment Metrics |
|
- |
- |
- |
- |
- |
- |
| Invested Capital |
|
0.00 |
2,515 |
2,502 |
2,392 |
2,530 |
2,588 |
| Invested Capital Turnover |
|
0.00 |
0.13 |
0.07 |
0.00 |
0.09 |
0.00 |
| Increase / (Decrease) in Invested Capital |
|
0.00 |
2,515 |
-13 |
-109 |
138 |
58 |
| Enterprise Value (EV) |
|
0.00 |
0.00 |
1,888 |
2,000 |
2,394 |
2,317 |
| Market Capitalization |
|
0.00 |
0.00 |
599 |
850 |
1,101 |
902 |
| Book Value per Share |
|
$0.00 |
$18.10 |
$17.29 |
$17.60 |
$17.65 |
$17.23 |
| Tangible Book Value per Share |
|
$0.00 |
$18.10 |
$17.29 |
$17.60 |
$17.65 |
$17.23 |
| Total Capital |
|
0.00 |
2,515 |
2,502 |
2,392 |
2,530 |
2,588 |
| Total Debt |
|
0.00 |
1,415 |
1,385 |
1,256 |
1,390 |
1,471 |
| Total Long-Term Debt |
|
0.00 |
1,415 |
1,385 |
1,256 |
1,390 |
1,471 |
| Net Debt |
|
0.00 |
1,211 |
1,289 |
1,150 |
1,293 |
1,415 |
| Capital Expenditures (CapEx) |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Net Nonoperating Expense (NNE) |
|
14 |
0.00 |
0.00 |
7.06 |
0.00 |
3.93 |
| Net Nonoperating Obligations (NNO) |
|
0.00 |
1,415 |
1,385 |
1,256 |
1,390 |
1,471 |
| Total Depreciation and Amortization (D&A) |
|
25 |
0.06 |
-1.04 |
-1.76 |
-1.13 |
0.05 |
| Earnings Adjustments |
|
- |
- |
- |
- |
- |
- |
| Adjusted Basic Earnings per Share |
|
$0.00 |
$0.00 |
$1.63 |
$1.91 |
$1.85 |
$1.53 |
| Adjusted Weighted Average Basic Shares Outstanding |
|
0.00 |
0.00 |
64.56M |
64.56M |
64.56M |
64.82M |
| Adjusted Diluted Earnings per Share |
|
$0.00 |
$0.00 |
$1.63 |
$1.91 |
$1.85 |
$1.53 |
| Adjusted Weighted Average Diluted Shares Outstanding |
|
0.00 |
0.00 |
64.56M |
64.56M |
64.56M |
64.82M |
| Adjusted Basic & Diluted Earnings per Share |
|
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Adjusted Weighted Average Basic & Diluted Shares Outstanding |
|
0.00 |
0.00 |
64.56M |
64.56M |
64.61M |
64.87M |
| Normalized Net Operating Profit after Tax (NOPAT) |
|
-33 |
73 |
84 |
-16 |
92 |
-9.17 |
| Normalized NOPAT Margin |
|
0.00% |
44.97% |
45.49% |
0.00% |
42.92% |
0.00% |
| Pre Tax Income Margin |
|
0.00% |
64.24% |
64.99% |
0.00% |
61.31% |
0.00% |
| Debt Service Ratios |
|
- |
- |
- |
- |
- |
- |
| EBIT to Interest Expense |
|
-0.75 |
2.04 |
2.29 |
-0.29 |
1.77 |
-0.16 |
| NOPAT to Interest Expense |
|
-0.52 |
2.04 |
2.29 |
-0.21 |
1.77 |
-0.11 |
| EBIT Less CapEx to Interest Expense |
|
-0.75 |
2.04 |
2.29 |
-0.29 |
1.77 |
-0.16 |
| NOPAT Less CapEx to Interest Expense |
|
-0.52 |
2.04 |
2.29 |
-0.21 |
1.77 |
-0.11 |
| Payout Ratios |
|
- |
- |
- |
- |
- |
- |
| Dividend Payout Ratio |
|
-181.94% |
83.81% |
73.32% |
-422.60% |
86.57% |
-1,113.70% |
| Augmented Payout Ratio |
|
-181.94% |
83.81% |
73.32% |
-422.60% |
86.57% |
-1,113.70% |
Quarterly Metrics And Ratios for Bain Capital Specialty Finance
This table displays calculated financial ratios and metrics derived from Bain Capital Specialty Finance's official financial filings.
| Metric |
|
Q4 2023 |
Q1 2024 |
Q2 2024 |
Q3 2024 |
Q4 2024 |
Q1 2025 |
Q2 2025 |
Q3 2025 |
Q4 2025 |
Q1 2026 |
Q2 2026 |
| DEI Shares Outstanding |
|
- |
- |
- |
- |
- |
- |
- |
- |
64,868,507.00 |
64,868,507.00 |
64,868,507.00 |
| DEI Adjusted Shares Outstanding |
|
- |
- |
- |
- |
- |
- |
- |
- |
64,868,507.00 |
64,868,507.00 |
64,868,507.00 |
| DEI Earnings Per Adjusted Shares Outstanding |
|
- |
- |
- |
- |
- |
- |
- |
- |
-0.30 |
-0.19 |
0.21 |
| Growth Metrics |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Revenue Growth |
|
-127.99% |
2,261.24% |
-7.60% |
250.07% |
287.08% |
-149.90% |
-23.74% |
-23.35% |
-190.72% |
68.32% |
47.96% |
| EBITDA Growth |
|
-126.38% |
725.68% |
-24.26% |
182.02% |
291.05% |
-189.79% |
-31.26% |
-28.47% |
-158.12% |
63.07% |
-2.40% |
| EBIT Growth |
|
-126.25% |
843.10% |
-25.00% |
182.91% |
293.55% |
-187.43% |
-31.67% |
-29.85% |
-157.36% |
63.24% |
-10.98% |
| NOPAT Growth |
|
-119.01% |
1,161.57% |
-25.00% |
218.44% |
376.50% |
-161.20% |
-31.67% |
-29.85% |
-140.15% |
63.24% |
-10.98% |
| Net Income Growth |
|
-123.70% |
843.10% |
-25.00% |
182.91% |
293.55% |
-187.43% |
-31.67% |
-29.85% |
-157.36% |
63.24% |
-10.98% |
| EPS Growth |
|
0.00% |
22.22% |
0.00% |
-1.92% |
-30.61% |
-20.00% |
-17.78% |
-43.14% |
26.47% |
-88.64% |
-40.54% |
| Operating Cash Flow Growth |
|
135.81% |
-48.26% |
2,293.15% |
-211.07% |
-113.44% |
88.59% |
-99.66% |
106.62% |
235.86% |
466.43% |
10,857.59% |
| Free Cash Flow Firm Growth |
|
0.00% |
102.69% |
112.66% |
103.43% |
-206.68% |
-275.51% |
-212.17% |
-279.78% |
30.39% |
132.44% |
136.25% |
| Invested Capital Growth |
|
-4.37% |
-1.15% |
-11.43% |
-2.22% |
5.75% |
3.82% |
16.63% |
7.26% |
2.30% |
-1.83% |
-4.45% |
| Revenue Q/Q Growth |
|
17.63% |
317.76% |
-20.17% |
4.81% |
2.68% |
-158.09% |
221.88% |
5.44% |
-221.62% |
79.73% |
376.47% |
| EBITDA Q/Q Growth |
|
53.50% |
318.71% |
-28.48% |
12.76% |
8.32% |
-202.79% |
154.68% |
17.50% |
-188.11% |
35.09% |
219.79% |
| EBIT Q/Q Growth |
|
53.05% |
322.04% |
-29.29% |
12.48% |
9.61% |
-200.30% |
155.18% |
15.63% |
-189.74% |
36.12% |
210.73% |
| NOPAT Q/Q Growth |
|
53.05% |
417.20% |
-29.29% |
12.48% |
9.61% |
-170.21% |
178.82% |
15.63% |
-162.82% |
36.12% |
258.18% |
| Net Income Q/Q Growth |
|
53.05% |
322.04% |
-29.29% |
12.48% |
9.61% |
-200.30% |
155.18% |
15.63% |
-189.74% |
36.12% |
210.73% |
| EPS Q/Q Growth |
|
-5.77% |
12.24% |
-18.18% |
13.33% |
-33.33% |
29.41% |
-15.91% |
-21.62% |
48.28% |
-88.37% |
340.00% |
| Operating Cash Flow Q/Q Growth |
|
21.56% |
-142.83% |
402.14% |
-170.60% |
85.29% |
63.63% |
108.89% |
1,292.57% |
201.81% |
-1.90% |
165.75% |
| Free Cash Flow Firm Q/Q Growth |
|
103.84% |
-29.74% |
379.39% |
-73.45% |
-219.30% |
-15.58% |
-206.34% |
57.44% |
53.83% |
153.82% |
245.83% |
| Invested Capital Q/Q Growth |
|
-4.41% |
4.50% |
-7.34% |
5.64% |
3.38% |
2.60% |
4.08% |
-2.84% |
-1.40% |
-1.55% |
1.31% |
| Profitability Metrics |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| EBITDA Margin |
|
0.00% |
62.56% |
56.05% |
60.30% |
63.61% |
0.00% |
50.50% |
56.27% |
0.00% |
0.00% |
56.57% |
| EBIT Margin |
|
0.00% |
63.50% |
56.24% |
60.35% |
64.42% |
0.00% |
50.36% |
55.23% |
0.00% |
0.00% |
51.44% |
| Profit (Net Income) Margin |
|
0.00% |
63.50% |
56.24% |
60.35% |
64.42% |
0.00% |
50.36% |
55.23% |
0.00% |
0.00% |
51.44% |
| Tax Burden Percent |
|
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
| Interest Burden Percent |
|
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
100.00% |
| Effective Tax Rate |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| Return on Invested Capital (ROIC) |
|
0.00% |
1.32% |
1.10% |
3.27% |
5.64% |
0.00% |
2.23% |
2.16% |
0.00% |
0.00% |
0.54% |
| ROIC Less NNEP Spread (ROIC-NNEP) |
|
0.00% |
1.32% |
1.10% |
3.27% |
5.64% |
0.00% |
2.23% |
2.16% |
0.00% |
0.00% |
0.54% |
| Return on Net Nonoperating Assets (RNNOA) |
|
0.00% |
1.55% |
1.29% |
3.83% |
6.55% |
0.00% |
2.68% |
2.66% |
0.00% |
0.00% |
0.75% |
| Return on Equity (ROE) |
|
-2.09% |
2.87% |
2.39% |
7.10% |
12.19% |
0.00% |
4.91% |
4.82% |
-1.16% |
0.00% |
1.29% |
| Cash Return on Invested Capital (CROIC) |
|
3.79% |
1.98% |
12.59% |
5.49% |
-0.23% |
-1.45% |
-13.36% |
-5.41% |
-2.63% |
2.17% |
4.80% |
| Operating Return on Assets (OROA) |
|
0.00% |
1.28% |
1.06% |
3.17% |
5.43% |
0.00% |
2.16% |
2.08% |
0.00% |
0.00% |
0.53% |
| Return on Assets (ROA) |
|
0.00% |
1.28% |
1.06% |
3.17% |
5.43% |
0.00% |
2.16% |
2.08% |
0.00% |
0.00% |
0.53% |
| Return on Common Equity (ROCE) |
|
-2.09% |
2.87% |
2.39% |
7.10% |
12.19% |
0.00% |
4.91% |
4.82% |
-1.16% |
0.00% |
1.29% |
| Return on Equity Simple (ROE_SIMPLE) |
|
0.00% |
1.83% |
1.02% |
7.00% |
0.00% |
5.13% |
4.38% |
3.60% |
0.00% |
0.77% |
0.62% |
| Net Operating Profit after Tax (NOPAT) |
|
-12 |
39 |
28 |
31 |
34 |
-24 |
19 |
22 |
-14 |
-8.76 |
14 |
| NOPAT Margin |
|
0.00% |
63.50% |
56.24% |
60.35% |
64.42% |
0.00% |
50.36% |
55.23% |
0.00% |
0.00% |
51.44% |
| Net Nonoperating Expense Percent (NNEP) |
|
0.40% |
0.00% |
0.00% |
0.00% |
0.00% |
0.73% |
0.00% |
0.00% |
0.41% |
0.26% |
0.00% |
| SG&A Expenses to Revenue |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| Operating Expenses to Revenue |
|
0.00% |
36.50% |
43.76% |
39.65% |
35.58% |
0.00% |
49.64% |
44.77% |
0.00% |
0.00% |
48.56% |
| Earnings before Interest and Taxes (EBIT) |
|
-18 |
39 |
28 |
31 |
34 |
-34 |
19 |
22 |
-20 |
-13 |
14 |
| Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA) |
|
-18 |
39 |
28 |
31 |
34 |
-35 |
19 |
22 |
-20 |
-13 |
15 |
| Valuation Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Price to Book Value (P/BV) |
|
0.75 |
0.80 |
0.85 |
0.89 |
0.97 |
0.94 |
0.86 |
0.82 |
0.81 |
0.74 |
0.75 |
| Price to Tangible Book Value (P/TBV) |
|
0.75 |
0.80 |
0.85 |
0.89 |
0.97 |
0.94 |
0.86 |
0.82 |
0.81 |
0.74 |
0.75 |
| Price to Revenue (P/Rev) |
|
0.00 |
17.43 |
20.20 |
7.58 |
5.11 |
8.73 |
8.77 |
9.32 |
0.00 |
41.91 |
29.09 |
| Price to Earnings (P/E) |
|
0.00 |
54.06 |
58.06 |
11.63 |
9.22 |
21.40 |
21.80 |
30.45 |
0.00 |
95.41 |
117.26 |
| Dividend Yield |
|
12.15% |
8.87% |
8.76% |
8.57% |
8.09% |
11.02% |
14.96% |
15.79% |
14.02% |
15.48% |
13.42% |
| Earnings Yield |
|
0.00% |
1.85% |
1.72% |
8.59% |
10.85% |
4.67% |
4.59% |
3.28% |
0.00% |
1.05% |
0.85% |
| Enterprise Value to Invested Capital (EV/IC) |
|
0.84 |
0.86 |
0.89 |
0.92 |
0.95 |
0.95 |
0.88 |
0.90 |
0.90 |
0.87 |
0.85 |
| Enterprise Value to Revenue (EV/Rev) |
|
0.00 |
41.14 |
42.80 |
16.88 |
11.12 |
20.00 |
21.33 |
23.72 |
0.00 |
116.10 |
78.70 |
| Enterprise Value to EBITDA (EV/EBITDA) |
|
0.00 |
110.55 |
194.62 |
28.43 |
18.29 |
42.59 |
48.33 |
58.46 |
0.00 |
256.82 |
264.71 |
| Enterprise Value to EBIT (EV/EBIT) |
|
0.00 |
102.93 |
177.10 |
28.18 |
18.13 |
41.89 |
47.54 |
57.92 |
0.00 |
264.32 |
326.88 |
| Enterprise Value to NOPAT (EV/NOPAT) |
|
0.00 |
102.93 |
177.10 |
28.18 |
18.13 |
41.89 |
47.54 |
57.92 |
0.00 |
264.32 |
326.88 |
| Enterprise Value to Operating Cash Flow (EV/OCF) |
|
9.12 |
10.82 |
5.16 |
15.98 |
0.00 |
83.83 |
0.00 |
0.00 |
78.49 |
35.13 |
16.45 |
| Enterprise Value to Free Cash Flow (EV/FCFF) |
|
21.54 |
43.07 |
6.64 |
16.65 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
39.85 |
17.33 |
| Leverage & Solvency |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Debt to Equity |
|
1.11 |
1.19 |
1.03 |
1.13 |
1.22 |
1.27 |
1.37 |
1.33 |
1.32 |
1.33 |
1.39 |
| Long-Term Debt to Equity |
|
1.11 |
1.19 |
1.03 |
1.13 |
1.22 |
1.27 |
1.37 |
1.33 |
1.32 |
1.33 |
1.39 |
| Financial Leverage |
|
1.17 |
1.18 |
1.17 |
1.17 |
1.16 |
1.23 |
1.20 |
1.23 |
1.27 |
1.30 |
1.38 |
| Leverage Ratio |
|
2.25 |
2.24 |
2.24 |
2.24 |
2.24 |
2.28 |
2.27 |
2.31 |
2.35 |
2.34 |
2.43 |
| Compound Leverage Factor |
|
2.25 |
2.24 |
2.24 |
2.24 |
2.24 |
2.28 |
2.27 |
2.31 |
2.35 |
2.34 |
2.43 |
| Debt to Total Capital |
|
52.50% |
54.30% |
50.68% |
53.15% |
54.95% |
55.91% |
57.84% |
57.01% |
56.83% |
57.09% |
58.15% |
| Short-Term Debt to Total Capital |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| Long-Term Debt to Total Capital |
|
52.50% |
54.30% |
50.68% |
53.15% |
54.95% |
55.91% |
57.84% |
57.01% |
56.83% |
57.09% |
58.15% |
| Preferred Equity to Total Capital |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| Noncontrolling Interests to Total Capital |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| Common Equity to Total Capital |
|
47.50% |
45.70% |
49.32% |
46.85% |
45.05% |
44.09% |
42.16% |
42.99% |
43.17% |
42.91% |
41.85% |
| Debt to EBITDA |
|
-49.67 |
69.90 |
110.84 |
16.34 |
10.62 |
25.14 |
31.82 |
37.17 |
-112.76 |
167.65 |
180.82 |
| Net Debt to EBITDA |
|
-45.47 |
63.70 |
102.78 |
15.66 |
9.88 |
24.00 |
28.46 |
35.50 |
-108.48 |
164.12 |
166.88 |
| Long-Term Debt to EBITDA |
|
-49.67 |
69.90 |
110.84 |
16.34 |
10.62 |
25.14 |
31.82 |
37.17 |
-112.76 |
167.65 |
180.82 |
| Debt to NOPAT |
|
-76.26 |
65.07 |
100.86 |
16.20 |
10.53 |
24.73 |
31.30 |
36.83 |
-160.48 |
172.54 |
223.28 |
| Net Debt to NOPAT |
|
-69.82 |
59.31 |
93.52 |
15.52 |
9.80 |
23.61 |
28.00 |
35.18 |
-154.39 |
168.91 |
206.08 |
| Long-Term Debt to NOPAT |
|
-76.26 |
65.07 |
100.86 |
16.20 |
10.53 |
24.73 |
31.30 |
36.83 |
-160.48 |
172.54 |
223.28 |
| Noncontrolling Interest Sharing Ratio |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| Liquidity Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Cash Flow Metrics |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Free Cash Flow to Firm (FCFF) |
|
97 |
68 |
327 |
87 |
-103 |
-120 |
-366 |
-156 |
-72 |
39 |
134 |
| Operating Cash Flow to CapEx |
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| Free Cash Flow to Firm to Interest Expense |
|
5.04 |
3.77 |
18.52 |
4.79 |
-4.95 |
-6.32 |
-16.82 |
-7.68 |
-3.67 |
1.91 |
6.48 |
| Operating Cash Flow to Interest Expense |
|
7.73 |
-3.53 |
10.91 |
-7.50 |
-0.96 |
-0.38 |
0.03 |
0.44 |
1.39 |
1.32 |
3.43 |
| Operating Cash Flow Less CapEx to Interest Expense |
|
7.73 |
-3.53 |
10.91 |
-7.50 |
-0.96 |
-0.38 |
0.03 |
0.44 |
1.39 |
1.32 |
3.43 |
| Efficiency Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Asset Turnover |
|
0.00 |
0.02 |
0.02 |
0.05 |
0.08 |
0.05 |
0.04 |
0.04 |
0.00 |
0.01 |
0.01 |
| Fixed Asset Turnover |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Capital & Investment Metrics |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Invested Capital |
|
2,392 |
2,500 |
2,316 |
2,447 |
2,530 |
2,596 |
2,702 |
2,625 |
2,588 |
2,548 |
2,581 |
| Invested Capital Turnover |
|
0.00 |
0.02 |
0.02 |
0.05 |
0.09 |
0.05 |
0.04 |
0.04 |
0.00 |
0.01 |
0.01 |
| Increase / (Decrease) in Invested Capital |
|
-109 |
-29 |
-299 |
-56 |
138 |
96 |
385 |
178 |
58 |
-47 |
-120 |
| Enterprise Value (EV) |
|
2,000 |
2,147 |
2,061 |
2,263 |
2,394 |
2,458 |
2,373 |
2,354 |
2,317 |
2,228 |
2,198 |
| Market Capitalization |
|
850 |
910 |
973 |
1,017 |
1,101 |
1,073 |
976 |
924 |
902 |
804 |
812 |
| Book Value per Share |
|
$17.60 |
$17.70 |
$17.70 |
$17.76 |
$17.65 |
$17.71 |
$17.56 |
$17.40 |
$17.23 |
$16.86 |
$16.65 |
| Tangible Book Value per Share |
|
$17.60 |
$17.70 |
$17.70 |
$17.76 |
$17.65 |
$17.71 |
$17.56 |
$17.40 |
$17.23 |
$16.86 |
$16.65 |
| Total Capital |
|
2,392 |
2,500 |
2,316 |
2,447 |
2,530 |
2,596 |
2,702 |
2,625 |
2,588 |
2,548 |
2,581 |
| Total Debt |
|
1,256 |
1,358 |
1,174 |
1,301 |
1,390 |
1,451 |
1,563 |
1,496 |
1,471 |
1,455 |
1,501 |
| Total Long-Term Debt |
|
1,256 |
1,358 |
1,174 |
1,301 |
1,390 |
1,451 |
1,563 |
1,496 |
1,471 |
1,455 |
1,501 |
| Net Debt |
|
1,150 |
1,237 |
1,089 |
1,246 |
1,293 |
1,385 |
1,398 |
1,429 |
1,415 |
1,424 |
1,385 |
| Capital Expenditures (CapEx) |
|
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Net Nonoperating Expense (NNE) |
|
5.29 |
0.00 |
0.00 |
0.00 |
0.00 |
10 |
0.00 |
0.00 |
5.88 |
3.75 |
0.00 |
| Net Nonoperating Obligations (NNO) |
|
1,256 |
1,358 |
1,174 |
1,301 |
1,390 |
1,451 |
1,563 |
1,496 |
1,471 |
1,455 |
1,501 |
| Total Depreciation and Amortization (D&A) |
|
-0.01 |
-0.58 |
-0.09 |
-0.03 |
-0.43 |
-0.41 |
0.05 |
0.41 |
-0.01 |
-0.21 |
1.38 |
| Earnings Adjustments |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Adjusted Basic Earnings per Share |
|
$0.49 |
$0.55 |
$0.45 |
$0.51 |
$0.34 |
$0.44 |
$0.37 |
$0.29 |
$0.43 |
$0.05 |
$0.22 |
| Adjusted Weighted Average Basic Shares Outstanding |
|
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.68M |
64.87M |
64.87M |
64.82M |
64.87M |
64.87M |
| Adjusted Diluted Earnings per Share |
|
$0.49 |
$0.55 |
$0.45 |
$0.51 |
$0.34 |
$0.44 |
$0.37 |
$0.29 |
$0.43 |
$0.05 |
$0.22 |
| Adjusted Weighted Average Diluted Shares Outstanding |
|
64.56M |
64.56M |
64.56M |
64.56M |
64.56M |
64.68M |
64.87M |
64.87M |
64.82M |
64.87M |
64.87M |
| Adjusted Basic & Diluted Earnings per Share |
|
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.47 |
$0.45 |
$0.00 |
$0.00 |
$0.44 |
| Adjusted Weighted Average Basic & Diluted Shares Outstanding |
|
64.56M |
64.56M |
64.56M |
64.56M |
64.61M |
64.87M |
64.87M |
64.87M |
64.87M |
64.87M |
64.87M |
| Normalized Net Operating Profit after Tax (NOPAT) |
|
-12 |
27 |
19 |
22 |
24 |
-24 |
13 |
15 |
-14 |
-8.76 |
9.70 |
| Normalized NOPAT Margin |
|
0.00% |
44.45% |
39.37% |
42.25% |
45.10% |
0.00% |
35.25% |
38.66% |
0.00% |
0.00% |
36.00% |
| Pre Tax Income Margin |
|
0.00% |
63.50% |
56.24% |
60.35% |
64.42% |
0.00% |
50.36% |
55.23% |
0.00% |
0.00% |
51.44% |
| Debt Service Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| EBIT to Interest Expense |
|
-0.92 |
2.17 |
1.57 |
1.72 |
1.63 |
-1.81 |
0.87 |
1.07 |
-1.00 |
-0.62 |
0.67 |
| NOPAT to Interest Expense |
|
-0.64 |
2.17 |
1.57 |
1.72 |
1.63 |
-1.27 |
0.87 |
1.07 |
-0.70 |
-0.43 |
0.67 |
| EBIT Less CapEx to Interest Expense |
|
-0.92 |
2.17 |
1.57 |
1.72 |
1.63 |
-1.81 |
0.87 |
1.07 |
-1.00 |
-0.62 |
0.67 |
| NOPAT Less CapEx to Interest Expense |
|
-0.64 |
2.17 |
1.57 |
1.72 |
1.63 |
-1.27 |
0.87 |
1.07 |
-0.70 |
-0.43 |
0.67 |
| Payout Ratios |
|
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
- |
| Dividend Payout Ratio |
|
-422.60% |
495.16% |
926.36% |
139.93% |
86.57% |
247.82% |
291.53% |
358.52% |
-1,113.70% |
1,477.26% |
1,823.62% |
| Augmented Payout Ratio |
|
-422.60% |
495.16% |
926.36% |
139.93% |
86.57% |
247.82% |
291.53% |
358.52% |
-1,113.70% |
1,477.26% |
1,823.62% |
Key Financial Trends
BCSF’s second quarter of 2026 showed a sharp operating recovery from the first quarter. Total interest income increased to $45.2 million from zero in Q1 2026, producing net interest income of $24.5 million versus a $20.3 million net interest loss. Total revenue reached $26.9 million, and net income attributable to common shareholders was reported at $14.1 million, compared with a $12.5 million loss in Q1. However, Q2 earnings remained below the $29.1 million reported in Q2 2024 and the $33.1 million reported in Q3 2024.
The latest balance sheet was relatively stable in size, with total assets of $2.62 billion at June 30, 2026, up modestly from $2.60 billion in Q1 but below $2.77 billion in Q2 2025. Cash and restricted cash totaled approximately $115.7 million, a substantial increase from $30.3 million in the prior quarter. Trading account securities represented $2.37 billion of assets, although this classification changed significantly across the historical periods provided, limiting direct portfolio comparisons. Long-term debt rose to $1.50 billion from $1.45 billion in Q1, while total equity declined to $1.08 billion.
Cash generation improved considerably in Q2 2026. Operating cash flow was $70.8 million, compared with $26.6 million in Q1 and only $0.6 million in Q2 2025. Debt issuance of $84.0 million exceeded $30.0 million of repayments, and the company paid $27.2 million in dividends. Still, Q2 operating cash flow benefited from $77.5 million of noncash adjustments and was reduced by a $22.1 million change in operating assets and liabilities. Investors should also note that many historical income statement and cash flow figures were restated or calculated, and several reported EPS values do not reconcile cleanly with the corresponding net income figures.
- Return to positive net interest income: Q2 2026 net interest income was $24.5 million after a $20.3 million loss in Q1, indicating that investment income resumed after the unusual first-quarter presentation.
- Stronger operating cash flow: Operating cash flow increased to $70.8 million in Q2 2026, providing substantially better support for dividends and financing needs.
- Improved liquidity: Cash and restricted cash increased by approximately $85.4 million sequentially to $115.7 million, while total cash increased by $97.5 million during the quarter.
- Dividend support: The company paid $27.2 million in dividends during Q2 while still producing positive operating cash flow and ending the quarter with a cash increase.
- Balance-sheet scale remained substantial: Total assets of $2.62 billion and common equity of $1.08 billion provide a sizeable capital base for the investment portfolio.
- Non-interest income was mixed: Other non-interest income of $15.3 million and service charges of $1.8 million largely offset a $14.7 million net realized and unrealized investment loss.
- Portfolio classification changed materially: Trading account securities increased from zero in Q3 2025 to more than $2.4 billion by Q1 2026, making long-term asset mix comparisons difficult without additional portfolio disclosures.
- Debt remains high: Long-term debt of $1.50 billion equaled roughly 57% of total assets, and interest expense increased to $20.7 million from $18.1 million in Q3 2024.
- Equity has weakened: Total common equity declined from $1.15 billion in Q2 2024 to $1.08 billion in Q2 2026, while retained earnings became more negative, reaching approximately $80.8 million below zero.
- Earnings remain volatile and difficult to evaluate: BCSF recorded losses in Q1 2025, Q4 2025 and Q1 2026, while investment gains and losses have caused large swings in reported revenue. Restatements and inconsistent EPS data further reduce the reliability of simple quarter-to-quarter comparisons.
09/05/26 12:41 AM ETAI Generated. May Contain Errors.